(Q48339775)

10 February 2018

title

Progesterone pharmacokinetics in the mouse: implications for potential stroke therapy. (English)

1 reference

10 February 2018

1 reference

Raymond Wong

1

1 reference

10 February 2018

David Ray

series ordinal

2

1 reference

10 February 2018

David A Kendall

series ordinal

3

1 reference

10 February 2018

publication date

4 June 2012

1 reference

10 February 2018

Journal of Pharmacy and Pharmacology

published in

1 reference

10 February 2018

volume

64

1 reference

10 February 2018

issue

11

1 reference

10 February 2018

page(s)

1614-1620

1 reference

10 February 2018

Is stroke the most common cause of disability?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Sex differences in stroke epidemiology: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Estrogen and coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Cardiovascular health and disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Estrogens and experimental ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Neuroprotective effects of female gonadal steroids in reproductively senescent female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone for the treatment of experimental brain injury; a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone: review of safety for clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Sustained levels of progesterone prior to the onset of cerebral ischemia are not beneficial to female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Neuroprotection for ischemic stroke: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Steroid synthesis and metabolism in the nervous system: trophic and protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

The metabolic clearance rate, head and brain extractions, and brain distribution and metabolism of progesterone in the anesthetized, female monkey (Macaca Mulatta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

The head extractions, brain and pituitary uptake and metabolism of progesterone and 5alpha-dihydroprogesterone in anesthetized, female rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Brain neurosteroids during the mouse oestrous cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

The resistance to ischemia of white and gray matter after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Is white matter involved in patients entered into typical trials of neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Neuroprotection for ischemic stroke: two decades of success and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

Animal models of stroke: do they have value for discovering neuroprotective agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01537.X

10.1111/J.2042-7158.2012.01537.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

23058048

1 reference

10 February 2018